IDEXX Labs (IDXX) Tops Q2 EPS by 19c; raises outlook
Get Alerts IDXX Hot Sheet
Price: $560.38 -1.13%
EPS Growth %: +15.5%
Financial Fact:
Gross profit: 246.73M
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
EPS Growth %: +15.5%
Financial Fact:
Gross profit: 246.73M
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Join SI Premium – FREE
IDEXX Labs (NASDAQ: IDXX) reported Q2 EPS of $2.67, $0.19 better than the analyst estimate of $2.48. Revenue for the quarter came in at $944 million versus the consensus estimate of $934.77 million.
GUIDANCE:
IDEXX Labs sees FY2023 EPS of $9.64-$9.90, versus the consensus of $9.69. IDEXX Labs sees FY2023 revenue of $3.66-3.715 billion, versus the consensus of $3.67 billion.
For earnings history and earnings-related data on IDEXX Labs (IDXX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Downgrades Norsk Hydro SA (NHY:NO) (NHYDY) to Neutral
- LKQ posts Q3 loss, replaces CEO amid Europe struggles
- Pfizer's 25-valent pneumococcal vaccine shows Phase 2 results
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share